These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 11524048

  • 1. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM, Su SF, Tsai CH, Lee YT, Wang SS.
    Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
    [Abstract] [Full Text] [Related]

  • 2. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002 Sep; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 3. Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6.
    Lee TM, Su SF, Hwang JJ, Tseng CD, Chen MF, Lee YT, Wang SS.
    Atherosclerosis; 2001 Oct; 158(2):471-6. PubMed ID: 11583728
    [Abstract] [Full Text] [Related]

  • 4. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
    Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
    [Abstract] [Full Text] [Related]

  • 5. Cilostazol: improving walking distance in patients with intermittent claudication.
    Collinson DJ, Donnelly R.
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):503-9. PubMed ID: 15225110
    [Abstract] [Full Text] [Related]

  • 6. Cilostazol for intermittent claudication.
    Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis DP, Stansby G.
    Cochrane Database Syst Rev; 2014 Oct 31; 2014(10):CD003748. PubMed ID: 25358850
    [Abstract] [Full Text] [Related]

  • 7. Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.
    de Albuquerque RM, Virgini-Magalhães CE, Lencastre Sicuro F, Bottino DA, Bouskela E.
    Angiology; 2008 Oct 31; 59(5):549-58. PubMed ID: 18388031
    [Abstract] [Full Text] [Related]

  • 8. A comparison of cilostazol and pentoxifylline for treating intermittent claudication.
    Dawson DL, Cutler BS, Hiatt WR, Hobson RW, Martin JD, Bortey EB, Forbes WP, Strandness DE.
    Am J Med; 2000 Nov 31; 109(7):523-30. PubMed ID: 11063952
    [Abstract] [Full Text] [Related]

  • 9. The effect of withdrawal of drugs treating intermittent claudication.
    Dawson DL, DeMaioribus CA, Hagino RT, Light JT, Bradley DV, Britt KE, Charles BE.
    Am J Surg; 1999 Aug 31; 178(2):141-6. PubMed ID: 10487267
    [Abstract] [Full Text] [Related]

  • 10. New treatment options in intermittent claudication: the US experience.
    Hiatt WR.
    Int J Clin Pract Suppl; 2001 Apr 31; (119):20-7. PubMed ID: 11355276
    [Abstract] [Full Text] [Related]

  • 11. Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication?
    Weismantel D.
    J Fam Pract; 2001 Feb 31; 50(2):181. PubMed ID: 11219570
    [No Abstract] [Full Text] [Related]

  • 12. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
    Money SR, Herd JA, Isaacsohn JL, Davidson M, Cutler B, Heckman J, Forbes WP.
    J Vasc Surg; 1998 Feb 31; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
    [Abstract] [Full Text] [Related]

  • 13. Cilostazol: treatment of intermittent claudication.
    Reilly MP, Mohler ER.
    Ann Pharmacother; 2001 Jan 31; 35(1):48-56. PubMed ID: 11197586
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of cilostazol and other therapies for intermittent claudication.
    Dawson DL.
    Am J Cardiol; 2001 Jun 28; 87(12A):19D-27D. PubMed ID: 11434896
    [Abstract] [Full Text] [Related]

  • 15. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL, Cutler BS, Meissner MH, Strandness DE.
    Circulation; 1998 Aug 18; 98(7):678-86. PubMed ID: 9715861
    [Abstract] [Full Text] [Related]

  • 16. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF, Davie AM, Clegg JP.
    Curr Med Res Opin; 2005 Jun 18; 21(6):817-26. PubMed ID: 15969881
    [Abstract] [Full Text] [Related]

  • 17. The effects of cilostazol on exercise-induced ischaemia-reperfusion injury in patients with peripheral arterial disease.
    O'Donnell ME, Badger SA, Sharif MA, Makar RR, McEneny J, Young IS, Lee B, Soong CV.
    Eur J Vasc Endovasc Surg; 2009 Mar 18; 37(3):326-35. PubMed ID: 19112032
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of cilostazol, a novel phosphodiesterase inhibitor in patients with intermittent claudication.
    Samra SS, Bajaj P, Vijayaraghavan KS, Potdar NP, Vyas D, Devani RG, Ballary C, Desai A.
    J Indian Med Assoc; 2003 Sep 18; 101(9):561-2, 564. PubMed ID: 15168999
    [Abstract] [Full Text] [Related]

  • 19. Cilostazol: a review of its use in intermittent claudication.
    Chapman TM, Goa KL.
    Am J Cardiovasc Drugs; 2003 Sep 18; 3(2):117-38. PubMed ID: 14727939
    [Abstract] [Full Text] [Related]

  • 20. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
    Beebe HG, Dawson DL, Cutler BS, Herd JA, Strandness DE, Bortey EB, Forbes WP.
    Arch Intern Med; 1999 Sep 27; 159(17):2041-50. PubMed ID: 10510990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.